山东孕妇强直脊柱炎(济南强直行脊柱炎医治) (今日更新中)

SAN DIEGO (KGTV) - The Drug Enforcement Agency launched a summer project drilling down on factors leading to violent crime across the nation. It is called Project Safeguard.Special Agent in Charge of the San Diego district, John Callery, said, "over 75% of those [violent] crimes are driven to get money to buy drugs."He said drugs and crime go hand in hand. "When a person devolves into a drug addict unfortunately they become very desperate right? And a desperate person will do desperate things to get money and buy drugs."Callery said his team geared up to knock out 15 cases with violent criminals. The arrests happened from August to October."We took a three month, for lack of a better word, a surge. Let’s get violent actors off the street. Let’s arrest them, DEA, and let’s charge them federally." Callery said they arrested 34 criminals.He added they have a lot of evidence to go through as well, "we’ve seized 71 firearms and... seized 160 kilograms of heroin and 160 kilograms of fentanyl."He hopes the arrests lead to hundreds more and reveal kingpins in the Mexican Drug Cartels."We’re a border town and we have a huge responsibility here to try and stop drugs from entering the United States because 75% of all drugs enter right here in our area and go to the rest of the United States." Callery said he is incredibly proud of his teamHe said five agents were infected with the novel coronavirus since March and have recovered. He said they haven't stopped working through the pandemic.Callery said his next big task is National Prescription Drug Take Back Day on October 24th. On takebackday.dea.gov you can find a collection site near you to drop unwanted, old medications so they don't get into the hands of children or others. 1753

SAN DIEGO (KGTV) — The Martin Luther King Jr. Community Choir San Diego has filled the community with music, funded dreams, and kept African American history alive for three decades.The group started with a local alliance of ministers from different denominations who came together for an annual concert to raise funds for students aspiring to a career in visual and performing arts, according to the choir director Kenneth Anderson."I think they are woefully undervalued in our country the power of art and how it can connect and communicate and bring people together when we're so driven apart," 20-year choir member Dale Fleming said.In 1990, the singers decided to created the MLK Community Choir so they could sing year-round.Andersen said, "It was non-audition but somehow all of these different timbres and levels of musicianship come together to make a beautiful sound."The religious tone of the group has changed over the years. "Some don't really believe at all but we all believe in the power of music," Fleming said.They still sing gospel, and write their own hymns to keep Black history alive."A majority of the spirituals that survived were code songs. When they sang about leaders in the bible, especially Moses, but Jesus and God, that was code for Harriet Tubman," Anderson explained.The group has flourished, touring through seven countries, creating and selling CDs, even singing for Pope John Paul II at the Vatican in 2004. You may have also seen them at December Nights."He was alive the next year but not well enough to come out, so we ended up being at his last Easter mass," Anderson said.The next time they perform is at 7 p.m. on Feb. 22 at St. James by the Sea in La Jolla. 1709

SAN DIEGO (KGTV) — The Department of Defense has awarded a San Diego biotech company up to million to help develop a next-generation drug to fight COVID-19.Sorrento Therapeutics calls the drug a “rapid countermeasure” against the disease, one that might serve as a vaccine substitute in certain populations or a critical stopgap tool if the virus mutates.“With this, we have a new platform potentially that can respond very quickly to any type of emerging threat,” said CEO Dr. Henry Ji.Sorrento is trying to become the first company to develop an approved DNA-encoded monoclonal antibody treatment. The approach is similar to the experimental monoclonal antibody treatment used on President Trump, but Sorrento’s concept is a more advanced version that offers several benefits.Sorrento’s drug is designed to be used as either a treatment in infected patients or a fast-forming layer of defense in healthy people. The company said its solution should be cheaper and easier to deploy than existing monoclonal antibodies, while offering vaccine-like protective effects that last for several months rather than just two or three weeks.Antibodies are one of the body’s key defense mechanisms. They seek out pathogens and bind to them, marking the invader for destruction like ground troops marking an enemy base for an airstrike. In some cases, antibodies can even neutralize an invader themselves by blocking its method of entry into cells.Monoclonal antibodies are antibodies designed by scientists to neutralize a pathogen. They are hand-picked, genetically modified super antibodies that are cloned in labs.However, the process of growing these super soldiers in the lab is difficult, transporting them requires a cold chain, and as a result, monoclonal antibodies are among the most expensive drugs in the world.Instead of giving people an infusion of pre-made antibodies, Sorrento’s idea is to give people a shot of DNA that instructs some of their cells to churn out perfectly pre-designed antibodies.“It's much easier to make enough DNA to treat a large number of people than it is to make enough protein to treat a large number of people. That’s just a fact about manufacturing,” said Dr. Robert Allen, Sorrento’s chief scientific officer on the project.Dr. Allen said the company is hopeful the drug will induce cells to make protective antibodies for six months or more.This DNA approach to an antibody treatment has never been approved for any disease but other companies are working on their own versions of it. Another biotech with ties to San Diego, Inovio Pharmaceuticals, became the first company to test this approach in humans in 2019 for a drug targeting the Zika virus.Sorrento’s approach is similar to the way DNA vaccines work, but it cuts out intermediary steps and jumpstarts the production of antibodies, rather than leaving the production of antibodies up to the body’s immune system. The result is that protective antibodies can start circulating in days after injection rather than weeks, the company said.“What this is capable of doing is it bypasses the need for the immune system,” said Dr. Mark Brunswick, Sorrento’s senior vice president for regulatory affairs.The drug is unlikely to replace a vaccine in most situations because vaccines can produce other defense mechanisms like T-cells that work in conjunction with antibodies. But the drug might work better than a vaccine for the elderly and others with weakened immune systems who are unable to produce a robust number of antibodies on their own, Brunswick said.Still, the company still has a lot of pre-clinical work and testing to go. Sorrento is hoping to have the drug ready for human trials in four to six months.By then, vaccines from Pfizer and Moderna will likely be widely available, but Dr. Ji said the world needs to prepare for the possibility this virus will mutate.“When you vaccinate hundreds of millions, potentially billions of people, the virus is under tremendous evolution pressure,” he said. “It will escape. It’s guaranteed that the virus is going to mutate and escape all of the vaccines we’re trying to create.”If it does, he said Sorrento will be ready to rapidly deploy its DNA-based countermeasure. 4223

SAN DIEGO (KGTV) - The debate over whether controversial guest speakers should be invited to a summit on reparations at San Diego State University re-erupted Wednesday after several protesters at a rally in favor of the invitations used anti-Semitic tropes that some witnesses called hate speech."We're all open to objective research on any given topic," Professor Risa Levitt told 10News. "But when hate speech enters the dialogue at a university that touts itself as being a leader in openness, acceptance, and diversity, then I think you do run into a problem."In 2019, the university agreed to fund a summit organized by students to explore the issues of reparations and slavery. One name floated as a potential speaker was Ava Muhammad, a spokesperson for the Nation of Islam who has been accused of anti-Semitism. When her name was suggested, a video was circulated showing her refer to Jews as "parasites" who taught Americans how to oppress freed slaves after the Civil War. When professors spoke out to suggest her invitation would be a mistake, the university said Muhammad would no longer be considered, explaining that the students in charge of the summit had decided she would not be invited.Wednesday's protest was held by the African People's Socialist Party and did not, according to organizers, include SDSU students as speakers, although one professor did speak. They made the case that no summit about reparations would be complete without another controversial leader accused of anti-Semitic remarks, Omali Yeshitela, chairman of the African People's Socialist Party. Yeshitela has previously been a guest speaker at SDSU.However, witnesses to the protest were disturbed by some of the language used, especially suggestions that rich Jewish people secretely run the university. One protestor called on students to boycott the summit to "...send a message to SDSU and their Zionist masters that we stand with Minister Ava and Chairman Omali.""A synagogue was shot 45 minutes from where we are right now," said SDSU student Dylan Meisner, referring to the deadly 2019 shooting at Chabad of Poway. "The argument is we cannot have people coming on campus who are going to say things that directly incite violence against Jewish people."Meisner says most students support free speech and believe that student groups are free to hear from whomever they want. However, he says this is different because the summit is funded by SDSU. "I personally was concerned, and I know many other students on campus were concerned, about the use of our tuition dollars being used to pay for a speech of people who have incited hatred against Jewish people in the past," Meisner said.A spokesperson for San Diego State says any characterization that the university banned, disallowed, or uninvited any speaker on the topic of reparations and slavery is incorrect. She says the details about the summit were only recent submitted by the student organizers and that those plans are currently going through the approval process. 3032

SAN DIEGO (KGTV) — The man wanted for a shooting outside of an unlicensed marijuana dispensary in unincorporated El Cajon has been arrested.The San Diego Sheriff's Department (SDSO) issued an arrest warrant for 18-year-old Richard Anthony Bell, of El Cajon, on Dec. 8 in connection with the shooting four days earlier in the 1600 block of N. 2nd Street.A 16-year-old was shot outside of the illegal dispensary and taken to a nearby hospital, where the victim remains and is expected to survive. Members of the U.S. Marshals Service located Bell on Friday at about 11 p.m. inside a hotel and casino on the Las Vegas Strip. He's being held on million bail for attempted murder and awaiting extradition back to San Diego County.The shooting isn't believed to be related to the dispensary and is thought to be gang-related, SDSO said. 841

来源：资阳报